Clinical trial Recruiting at 2 sites Observational Ages 55 to 74

Lung cancer screening for workers exposed to harmful substances

Official title: LUng Cancer Screening With Low-dose Computed Tomography in a Population Exposed to Occupational Lung Carcinogens

Run by Centre Hospitalier Intercommunal Creteil · NCT03562052 · Data updated 2026-11-12

This study is testing if low-dose chest CT scans can help find lung cancer early in smokers aged 55 to 74 who have been exposed to harmful substances at work.

Quick facts

Study typeObservational
Ages55 Years to 74 Years
SexAll
Enrollment6000 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Locations8 sites (Bordeaux and 7 other locations)
StatusRecruiting
StartedJuly 22, 2021
Main results expectedJuly 2026
Study endsJuly 31, 2031
Registry record updatedJuly 9, 2024
Trial IDNCT03562052 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are current or former smokers aged 55 to 74 with significant occupational exposure to known lung carcinogens.

Probably not a fit

Patients with a history of lung cancer, serious comorbidities, or those who have not been exposed to occupational carcinogens will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of lung cancer screening using low-dose chest CT scans in a high-risk population of smokers aged 55 to 74 who have been exposed to occupational lung carcinogens. It aims to assess the organization of screening activities, the validity of self-administered questionnaires for identifying high-risk individuals, and the effectiveness of lung cancer detection methods. The study will also monitor smoking cessation rates among participants over a two-year period.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection of lung cancer in high-risk workers, potentially saving lives.

How similar studies have gone: Other studies have shown success with lung cancer screening in high-risk populations, indicating that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Subjects at high risk of lung cancer: current smokers smoking 30 pack-years or more or ex-smokers smoking 30 pack-years or more and who have quit smoking for less than 15 years and currently or previously occupationally exposed to lung carcinogens. With an algorithm for determination of minimal duration of exposure to occupational carcinogens (according to the type and duration of occupational lung carcinogens)

Exclusion Criteria:

* Presence of clinical signs of lung cancer
* Subjects with a history of lung cancer
* Presence of serious short-term life-threatening comorbidities
* Absence of occupational exposure to lung carcinogens according to the predefined criteria
* Subjects already included in another prospective cohort study
* Subjects already assessed by chest CT scan during the previous year
* No tobacco exposure or insufficient tobacco exposure or smoking cessation for more than 15 years.

Where it's running

  • Centre Hospitalier Universitaire de Bordeaux
    Bordeaux, France
    Recruiting
  • Centre Hospitalier Intercommunal de Créteil
    Créteil, France
    Recruiting
  • Université de Bordeaux
    Bordeaux, France
    Active not recruiting
  • Centre Hospitalier Universitaire de Brest
    Brest, France
    Not yet recruiting
  • Centre Hospitalier Universitaire de Caen
    Caen, France
    Not yet recruiting
  • Centre Hospitalier Universitaire de Rennes
    Rennes, France
    Not yet recruiting
Show 2 more locations
  • Centre Hospitalier Universitaire de Rouen
    Rouen, France
    Not yet recruiting
  • Hôpital d'Instruction des Armées Sainte-Anne
    Toulon, France
    Not yet recruiting

Study contacts

  • Principal investigator: Jean-Claude Pairon, Pr — Centre Hospitalier Interconnmunal de Créteil
  • Study coordinator: Jean-Claude Pairon, Pr
  • Email: JC.Pairon@chicreteil.fr
  • Phone: 157022093

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.